Sunshine Biopharma files 8-K on placement agreement

Sunshine Biopharma said it entered into a placement agent agreement with Aegis Capital Corp. for a best efforts public offering that closed Oct. 9. The company said gross proceeds were about $6 million before fees and expenses.